In humans, mutations in MC4R are the most common cause of genetic obesity (2, 4) and the use of setmelanotide, an MC4R agonist, is an effective pharmacotherapy for the treatment of monogenetic and syndromic obesity phenotypes (5, 6). Here, MC4R is linked to Obesity.